Category Archives: Marijuana (Cannabinoids)

The relationship between cannabis use and early psychosis

It’s part of the highlights of the 5th International Conference on Early Psychosis held in Birmingham, UK and published on Medscape.

Here are the highlights of the highlights as they relate to marijuana and psychosis — a mental disorder characterized by delusions or hallucinations that indicate impaired contact with reality. Continue reading The relationship between cannabis use and early psychosis →

Marijuana use not associated with lung cancer

People who smoked marijuana in their youth are getting to the age when cancers are seen. Therefore, we’re probably on the verge of seeing many studies on the effects marijuana’s long-term health consequences.

Among more than 2000 people living in Los Angeles County, long-term marijuana users who smoked more than 22,000 joints over a lifetime showed no greater risk than infrequent marijuana users or nonusers.

How could this be?

Continue reading Marijuana use not associated with lung cancer →

Insufficient proof of efficacy for marijuana spray to permit sale in the UK

GW Pharmaceuticals was able to prove that Sativex, their marijuana oral spray product, was safe and reliably contained sufficient tetrahydrocannabinol. But proof of effectiveness was lacking, in the view of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) Continue reading Insufficient proof of efficacy for marijuana spray to permit sale in the UK →

The Volcano alternative means of delivery of inhaled Cannabis sativa

An earlier study (reported here, discussed here) showed that the Volcano vaporization device is a reliable way to achieve lung concentrations of marijuana.

Now, researchers from the University of California and San Francisco General Hospital confirm that vaporization of cannabis is a safe and effective mode of delivery of tetrahydrocannabinol (THC). They think the device should be used in future studies of THC. Continue reading The Volcano alternative means of delivery of inhaled Cannabis sativa →

Cannabinoid-receptor blocker will probably not be sold in the US

The New York Times reports, “The [FDA] advisory panel voted unanimously, 14 to 0, against recommending the drug [rimonabant, Acomplia, Zimulti], saying there was inadequate evidence of its safety. The FDA is not required to follow this advice, but it typically does.”

The report is interesting to this blog because rimonabant works by blocking cannabinoids receptors in the brain. Continue reading Cannabinoid-receptor blocker will probably not be sold in the US →

Self-care for peripheral neuropathy in HIV/AIDS

Peripheral neuropathy is the most common neurological complication in HIV, and it’s often associated with antiretroviral therapy. Patients experience muscle weakness and atrophy, pain, and numbness.

Here’s what people use to manage the discomfort. Continue reading Self-care for peripheral neuropathy in HIV/AIDS →